Gut Microbiota’s Influence on Eating Behavior and Obesity Treatment Strategies

This review highlights the relationship between the gut microbiota and eating behavior, suggesting that while gut microbes may influence appetite and obesity, more evidence is needed before microbiota-based therapies can be applied clinically.

Mechanisms of Feeding Regulation and Dysregulation

In examining the physiological factors that affect food consumption, researchers note that feeding regulation involves a complex interplay between hedonic and homeostatic neural systems. Short-term and long-term hormonal signals, such as ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and leptin, play critical roles in meal timing and energy homeostasis. Disruption in these systems leads to obesity and eating disorders by affecting satiety and hunger cues, reactions which can result in overeating or restrictive behaviors.

The Role of Gut Microbiota in Eating Disorders

The microbiota-gut-brain axis facilitates communication between the central nervous system and intestinal microbiota via multiple pathways. This interaction underlines the gut microbiota’s role in regulating both reward and appetite-signal balance. Dysbiosis, or imbalance in gut microbiota composition, has been associated with obesity and eating disorders, as it can impair the body’s capacity to manage hunger and fullness. Evidence suggests that changes in gut microbiota can contribute to compulsive eating behaviors and obesity by affecting reward processing pathways in the brain.

Emerging Therapeutic Approaches Targeting Gut Microbiota

Potential strategies for obesity management that involve the gut microbiota include prebiotics, probiotics, and synbiotics. For instance, resistant starch demonstrated benefits in weight management and metabolic health in a small study involving adults with obesity. Furthermore, clinical trials on specific probiotic strains have shown promise in improving metabolic health outcomes. However, these trials largely remain small, and further validation through larger studies is essential. Additionally, postbiotics and Fecal Microbiota Transplantation (FMT) have been explored, although their outcomes have varied and require further investigation to determine their effectiveness for significant weight loss.

THE CNP TAKEAWAY

The findings underscore the potential role of gut microbiota in influencing eating behaviors and obesity, though more extensive research is critical to establish effective interventions. Until then, microbiota-targeted therapies should not be considered standard treatment options.

Images courtesy of Shutterstock.

This article was prepared by CNP based on the news article entitled “Gut microbiota as a novel therapeutic target for eating disorders and obesity by Samulėnaitė, S., Mathis, V., Darcq, E., Burokas, A., Martín-García, E., & Maldonado, R. Read the original news article on news-medical.net or find the CNP study summary in the NPRL.